INMB logo

INMB

INmune Bio Inc.

$2.03
-$0.06(-2.87%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$57.42M
Volume
541.37K
52W Range
$1.89 - $11.64
Target Price
$9.65
Order:

Income Statement

MetricTrendChart
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
----$11.0K$181.0K$374.0K$155.0K$14.0K
Total Revenue
----$11.0K$181.0K$374.0K$155.0K$14.0K
GROSS PROFIT
Gross Profit
----$11.0K$181.0K$374.0K$155.0K$14.0K
OPERATING EXPENSES
Operating Expenses
$-12.4M$7.8M$12.2M$29.3M$26.3M$29.9M$42.6M
Research & Development
$3.4M$3.3M$5.9M$20.5M$17.1M$20.3M$33.2M
Research Expense
$3.4M$3.3M$5.9M$20.5M$17.1M$20.3M$33.2M
Selling, General & Administrative
$9.1M$6.0M$6.3M$8.8M$9.3M$9.6M$9.5M
General & Administrative Expenses
$9.1M$6.0M$6.3M$8.8M$9.3M$9.6M$9.5M
Salaries & Wages
$-10.0M$-4.1M$3.1M$4.8M$1.0M$7.4M$7.6M
Other Operating Expenses
--$-1.5M--$1.2M$209.0K$163.0K$161.0K
OPERATING INCOME
Operating income
$-12.4M$-7.8M$-12.2M$-29.2M$-26.0M$-29.7M$-42.6M
EBITDA
$-12.4M$-7.7M$-12.2M$-29.2M$-26.0M$-34.0M$-50.1M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
------$985.0K$2.0M$2.3M$789.0K
Intinc
--$77.7K----------
Net Non-Operating Interest Income/Expense
--$77.7K--$-985.0K$-2.0M$-2.3M$-789.0K
Other Income/Expense
--$-77.7K$-129.0K$2.0K$-1.3M$267.0K$-553.0K
Other Special Charges
--$77.7K$129.0K$-2.0K$-1.3M$-267.0K$553.0K
PRE-TAX INCOME
EBIT
$-12.4M$-7.7M$-12.2M$-29.2M$-26.0M$-34.0M$-50.1M
Pre-Tax Income
$-12.4M$-7.7M$-12.1M$-30.3M$-27.3M$-30.0M$-42.1M
INCOME TAX
Tax Provision
$-71.0K$159.2K$-2.5M$-6.4M$-5.7M$-6.3M$-8.8M
NET INCOME
Net Income
$-12.4M$-7.7M$-12.1M$-30.3M$-27.3M$-30.0M$-42.1M
Net Income (Continuing Operations)
$-12.4M$-7.7M$-12.1M$-30.3M$-27.3M$-30.0M$-42.1M
Net Income (Discontinued Operations)
$-12.4M$-7.7M$-12.1M$-30.3M$-27.3M$-30.0M$-42.1M
Net Income (Common Stockholders)
$-12.4M$-7.7M$-12.1M$-30.3M$-27.3M$-30.0M$-42.1M
Normalized Income
------$-36.7M----$-50.9M
TOTALS
Total Expenses
$-12.4M$7.8M$12.2M$29.3M$26.3M$29.9M$42.6M
SHARE & EPS DATA
Average Shares Outstanding
$8.7M$10.3M$12.0M$16.1M$17.9M$18.0M$19.9M
Average Shares Outstanding (Diluted)
$8.7M$10.3M$12.0M--$17.9M$18.0M$19.9M
Shares Outstanding
$26.6M$10.7M$14.9M$17.9M$17.9M$26.6M$26.6M
Basic EPS
----$-1.01$-1.88$-1.52$-1.67$-2.11
Basic EPS (Continuing Operations)
----$-1.01$-1.88$-1.52$-1.67$-2.11
Diluted EPS
$-1.43$-0.75$-1.01$-1.88$-1.52$-1.67$-2.11
Diluted EPS (Continuing Operations)
--$-0.75----$-1.52$-1.67$-2.11
OTHER METRICS
Other Gand A
$9.1M$6.0M$6.3M$8.8M$9.3M$9.6M$9.5M
Rent And Landing Fees
$9.1M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2INMB$2.03-2.9%541.37K
3
4
5
6

Get INmune Bio Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.